Patient education and WOC nurse specialists could play roles in improving outcomes after ostomy surgery.
PAS continues to spearhead research in understanding outcomes of COVID-19 and its impact on pregnant women, increased risk of myocarditis and healthcare resource utilization.
There is an urgent need to understand the clinical and economic consequences associated with AKI in hospitalized patients with COVID-19 to better inform treatment decisions...
The SARS-Cov-2 delta variant has filled U.S. hospitals to capacity reinforcing the need for data to better understand disease severity and support evidence-based treatment decisions...
Premier Applied Sciences and Meitheal Pharmaceuticals collaborate to study anticoagulant use in COVID-19 patients.
A new study conducted via the U.S. Premier Healthcare Database revealed nearly one in every four Covid-19 deaths may be attributed to hospital strain.
See how we're leveraging our rich data sets to uncover new oncology insights.
Premier's Roni Christopher weighs in on the FDA's approval of a Biogen treatment for patients with Alzheimer's disease.
Premier Applied Sciences to analyze study results and evaluation of the product aimed at improving outcomes and lowering costs for male urinary disorders.
This paper examines the uptake and accuracy of diagnosis for COVID-19 in U.S. hospitals.
Premier's Ning Rosenthal discusses findings from a recent study that looked at patients with COVID-19 in US acute care hospitals.
GE Healthcare and Premier Applied Sciences® selected St. Luke’s as an ideal pilot site for the One-Stop Clinic breast care model.
Using the Premier Healthcare Database, this study looked at patients with COVID-19 in US acute care hospitals and high ICU admission and in-hospital mortality rates.
This study used a performance platform to enhance clinicians' management of patients with diabetes and osteoporosis.
Finding the right patients and providing a catalyst for change in behavior and treatment has an incredible amount of potenital. Learn how to support care...
Premier's Myla Maloney discusses how health systems and life sciences companies are using data to change COVID-19 care.
Myla Maloney talks about what makes the PHD unique, and how biopharma can leverage data to learn how their drugs perform in the real world.
Learn how Premier’s dynamic stability solutions allow organizations to predict disruptions and use data to adapt to today’s changing and turbulent healthcare environment.
Premier's Dr. Safo is using her experience in HIV/AIDS medicine to inform Premier’s work on population health.
Severe maternal morbidity factors can force women to stay hospital-bound for 70% longer, the analysis found.
Women are more likely to experience an unexpected outcome during delivery and it's adding to hospital costs, according to a new analysis from Premier.
Premier's Susan DeVore ranked 29th on the list.
When it comes to maternal and infant health, healthcare providers and lawmakers have been flying blind with many lives at stake.
As your leading research and analytics partner, PINC AI™ Applied Sciences can help your organization improve the overall quality, safety and cost-effectiveness of care.